Skip to main content

mycophenolic acid

Generic: mycophenolic acid·Brand: Myfortic

mycophenolic acid: 2 clinical trials tracked.

mycophenolic acid evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about mycophenolic acid, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Cytomegalovirus Infection

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trials (2)

Donor-derived Mesenchymal Stromal Cells, Alemtuzumab, Co-stimulation Blockade and Sirolimus for Tolerance Induction in Adult Kidney Allograft Recipients (ITN062ST)

NCT03504241·Phase 1
Completed

Primary endpoint: Proportion of Participants who Achieve Operational Tolerance

Interventionalopen8 enrolledStarted 2018-07Completion 2025-091 site · United StatesNational Institute of Allergy and Infectious Diseases (NIAID)

A Multicenter, Two Arms, Randomized, Open Label Clinical Phase IV Study Investigating the Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection Within the First 6 Months Post-transplantation When Treated With an Immunosuppressive Regimen Including Everolimus (Certican®) and Reduced Dose of Cyclosporine A (Neoral®) Versus an Immunosuppressive Regimen With Mycophenolic Acid (Myfortic®) and Standard Dose of Cyclosporine A (Neoral®).

NCT02328963·Phase 4
Completed

Primary endpoint: Number of participants without CMV infection and without graft loss in CMV seropositive kidney transplant recipients.

InterventionalRandomizedopen186 enrolledStarted 2014-05Completion 2018-109 sites · FranceUniversity Hospital, Bordeaux